Search research articles
Contact Us
Filters
Showing results (31-40 of 102) with videos related to
Page
of 11
Sort By:
Chemical Reviews
|
December 26, 2001
Non-platinum chemotherapeutic metallopharmaceuticals
M J Clarke, F Zhu, D R Frasca
Singapore Medical Journal
|
June 1, 2007
Diabetic fibrous mastopathy
R Lakshmanan, M J Clarke, T C Putti
Molecular and Cellular Biochemistry
|
April 11, 1989
Binding of the transition metal ion [(H2O)(NH3)5Ru(II)]2+ to nucleosomal core and internucleosomal DNA
K A Marx, R Kruger, M J Clarke
BMJ (Clinical Research Ed.)
|
November 2, 1996
Identifying reports of controlled trials in the BMJ and the Lancet
S J McDonald, C Lefebvre, M J Clarke
JAMA
|
September 13, 1995
From science to practice. Meta-analyses using individual patient data are needed
A D Oxman, M J Clarke, L A Stewart
Chemico-Biological Interactions
|
September 1, 1980
Mutagenic and toxic effects of ruthenium
R E Yasbin, C R Matthews, M J Clarke
Journal of Pharmaceutical Sciences
|
February 13, 2001
The formulation of powder inhalation systems containing a high mass of nedocromil sodium trihydrate
M J Clarke, M J Tobyn, J N Staniforth
Journal of Pharmaceutical Sciences
|
August 16, 2000
Physicochemical factors governing the performance of nedocromil sodium as a dry powder aerosol
M J Clarke, M J Tobyn, J N Staniforth
Journal of Inorganic Biochemistry
|
March 10, 2001
Cellular effects of transferrin coordinated to
D R Frasca, L E Gehrig, M J Clarke
Biological Trace Element Research
|
November 21, 2013
Determination of ruthenium on DNA by XRF
L Wielopolski, R Zhang, M J Clarke, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 102) with videos related to
Sort By:
Page
of 11
Chemical Reviews
|
December 26, 2001
Non-platinum chemotherapeutic metallopharmaceuticals
M J Clarke, F Zhu, D R Frasca
Singapore Medical Journal
|
June 1, 2007
Diabetic fibrous mastopathy
R Lakshmanan, M J Clarke, T C Putti
Molecular and Cellular Biochemistry
|
April 11, 1989
Binding of the transition metal ion [(H2O)(NH3)5Ru(II)]2+ to nucleosomal core and internucleosomal DNA
K A Marx, R Kruger, M J Clarke
BMJ (Clinical Research Ed.)
|
November 2, 1996
Identifying reports of controlled trials in the BMJ and the Lancet
S J McDonald, C Lefebvre, M J Clarke
JAMA
|
September 13, 1995
From science to practice. Meta-analyses using individual patient data are needed
A D Oxman, M J Clarke, L A Stewart
Chemico-Biological Interactions
|
September 1, 1980
Mutagenic and toxic effects of ruthenium
R E Yasbin, C R Matthews, M J Clarke
Journal of Pharmaceutical Sciences
|
February 13, 2001
The formulation of powder inhalation systems containing a high mass of nedocromil sodium trihydrate
M J Clarke, M J Tobyn, J N Staniforth
Journal of Pharmaceutical Sciences
|
August 16, 2000
Physicochemical factors governing the performance of nedocromil sodium as a dry powder aerosol
M J Clarke, M J Tobyn, J N Staniforth
Journal of Inorganic Biochemistry
|
March 10, 2001
Cellular effects of transferrin coordinated to
D R Frasca, L E Gehrig, M J Clarke
Biological Trace Element Research
|
November 21, 2013
Determination of ruthenium on DNA by XRF
L Wielopolski, R Zhang, M J Clarke, et al.
Page
of 11